Follow-up actions for patients with a family history of breast cancer regarding mammography include offering annual mammographic surveillance to women aged 40 to 69 years at high or moderate risk, depending on their specific risk level and genetic status NICE CG164.
For women aged 50 years and over with a family history, mammography should be offered as part of the population screening programme, especially if they have a greater than 30% probability of being a BRCA or TP53 carrier NICE CG164.
It is important to review eligibility for surveillance if the family history changes, such as if another family member develops breast cancer or a mutation is identified NICE CG164.
Women should be given information about the surveillance programme, including the tests, frequency, duration, and the risks and benefits involved, at the start and when there are changes to the plan NICE CG164.